Additionally, individuals with genetic predispositions identified through testing like PlexusDx's Precision Peptide Genetic Test may show enhanced response to GLP-1 pathways regardless of baseline BMI
Exenatide demonstrated significant efficacy in improving glycemic control in patients with type 2 diabetes
Ultimately, individuals must weigh their circumstances, considering factors such as the potential for weight regain following gastric bypass surgery and the effectiveness of semaglutide in assisting their weight loss expedition
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
More recently, semaglutide has also been used for weight loss
Ongoing monitoring and tailored interventions are critical, especially as patients may experience fluctuating weight or continued treatment with GLP-1 RAs
